By
Médecins Sans Frontières
Published: Nov. 24, 2023, 8:17 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Diagnostics,
Access,
Advocacy
Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.
Read More →
By
UNITE4TB
Published: Nov. 24, 2023, 7:54 p.m.·
Tags:
Treatment,
Scientific research
An international survey seeks to determine the most important outcomes to measure in Phase 3 trials of pulmonary TB treatment.
Read More →
By
Stop TB Partnership
Published: Nov. 24, 2023, 6:15 p.m.·
Tags:
TB care,
Advocacy
The TB REACH Wave 11 call for proposals is focused on innovative approaches to integrate TB service delivery with lung health at the primary and community level of the health systems.
Read More →
By
World Health Organization
Published: Nov. 24, 2023, 4:38 p.m.·
Tags:
Drug-resistant TB,
Diagnostics,
Guidelines
The World Health Organization issues two new guidance documents to support implementation of next generation sequencing to detect drug-resistant TB.
Read More →
By
TB Alliance
Published: Nov. 16, 2023, 10:46 p.m.·
Tags:
Drug-sensitive TB,
Drug-resistant TB,
Treatment
A combination of a new experimental compound, TBAJ-876, with pretomanid and linezolid, has the potential to become a 'universal TB regimen', shortening and improving treatment for both drug-sensitive and drug-resistant TB.
Read More →
By
Desmond Tutu TB Centre, Stellenbosch University
Published: Nov. 16, 2023, 8:29 p.m.·
Tags:
Drug-resistant TB,
Prevention
Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults.
Read More →
By
endTB
Published: Nov. 15, 2023, 10:02 p.m.·
Tags:
Drug-resistant TB,
Treatment
endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug–resistant TB.
Read More →
By
TB Alliance
Published: Nov. 15, 2023, 8:37 p.m.·
Tags:
Drug-resistant TB,
Treatment
Results of LIFT-TB operational research on BPaL regimen for treating drug-resistant TB in Central and Southeast Asia.
Read More →
By
World Health Organization
Published: Nov. 14, 2023, 7:51 p.m.·
Tags:
Global TB response,
Pediatrics
The roadmap outlines an ambitious five-year plan with 10 key actions to improve the prevention, treatment, and care of TB in children and adolescents.
Read More →
By
Treatment Action Group
Published: Nov. 13, 2023, 9:37 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.
Read More →
Page 6 of 133 · Total posts: 10
←First
5
6
7
Last→